0001209191-23-017904.txt : 20230310 0001209191-23-017904.hdr.sgml : 20230310 20230310172245 ACCESSION NUMBER: 0001209191-23-017904 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230308 FILED AS OF DATE: 20230310 DATE AS OF CHANGE: 20230310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jacobs Jeffrey Scott CENTRAL INDEX KEY: 0001809266 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38467 FILM NUMBER: 23724894 MAIL ADDRESS: STREET 1: C/O CERIDIAN HCM HOLDING INC. STREET 2: 3311 EAST OLD SHAKOPEE ROAD CITY: MINNEAPOLIS STATE: MN ZIP: 55425 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ceridian HCM Holding Inc. CENTRAL INDEX KEY: 0001725057 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 463231686 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3311 EAST OLD SHAKOPEE ROAD CITY: MINNEAPOLIS STATE: MN ZIP: 55425 BUSINESS PHONE: 952-853-8100 MAIL ADDRESS: STREET 1: 3311 EAST OLD SHAKOPEE ROAD CITY: MINNEAPOLIS STATE: MN ZIP: 55425 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-03-08 0 0001725057 Ceridian HCM Holding Inc. CDAY 0001809266 Jacobs Jeffrey Scott C/O CERIDIAN HCM HOLDING INC. 3311 E. OLD SHAKOPEE ROAD MINNEAPOLIS MN 55425 0 1 0 0 Head of Acct & Fin Reporting Common Stock 2023-03-09 4 S 0 255 71.69 D 18476 D Common Stock 2023-03-08 4 M 0 823 A 19299 D Common Stock 2023-03-09 4 S 0 255 71.69 D 19044 D Option (right to buy) 17.58 2025-12-08 Common Stock 500 500 D Option (right to buy) 16.82 2026-12-31 Common Stock 1125 1125 D Option (right to buy) 19.04 2027-12-20 Common Stock 5000 5000 D Option (right to buy) 22.00 2028-04-25 Common Stock 32610 32610 D Option (right to buy) 44.91 2029-02-08 Common Stock 712 712 D Option (right to buy) 49.93 2029-03-20 Common Stock 8396 8396 D Option (right to buy) 65.26 2030-05-08 Common Stock 14299 14299 D Performance Units 2023-03-08 4 M 0 823 0.00 D 2031-03-08 Common Stock 823 824 D Performance Units 2032-02-24 Common Stock 2352 2352 D Performance Units 2033-02-28 Common Stock 845 845 D 255 shares of common stock of the Issuer ("Common Stock") were sold to cover withholding taxes as required pursuant to the terms of the restricted stock unit ("RSU") award agreement and 568 shares of Common Stock were issued to the Reporting Person in connection with the vesting of 823 RSUs on March 8, 2023. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.69 to $71.73 inclusive. The reporting person undertakes to provide Ceridian HCM Holding Inc., any security holder of Ceridian HCM Holding Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Given the Company's performance in 2021 and pursuant to the terms of the performance stock unit ("PSU") award agreement, each PSU granted on March 8, 2021 converted into 1 share of Common Stock upon vesting. The vesting of 823 occurred on March 8, 2023, and the vesting of 824 PSUs occurs on March 8, 2024. 255 shares of Common Stock were sold to cover withholding taxes as required pursuant to the terms of the PSU award agreement and 568 shares of Common Stock were issued to the Reporting Person in connection with the vesting of 823 PSUs on March 8, 2023. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.6718 to $71.69 inclusive. The reporting person undertakes to provide Ceridian HCM Holding Inc., any security holder of Ceridian HCM Holding Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes (i) 6,658 shares of Common Stock, (ii) shares of Common Stock issuable pursuant to RSUs, granted on May 8, 2020, of which 511 shares vest on May 8, 2023; (iii) shares of Common Stock that are issuable pursuant to RSUs, granted on March 8, 2021, of which 824 shares vest on March 8, 2024; (iv) shares of Common Stock issuable pursuant to RSUs, granted on February 24, 2022, of which 1,412 shares vest on each of February 24, 2024 and February 24, 2025; and (v) shares of Common Stock issuable pursuant to RSUs, granted on February 28, 2023, of which 2,742 shares vest on each of February 28, 2024 and February 28, 2025, and 2,743 shares vest on February 28, 2026. Fully vested and exercisable. Consists of 6,297 vested and exercisable options as of March 20, 2022, and 2,099 options that vest and become exercisable on March 20, 2023. Consists of 7,149 vested and exercisable options as of May 8, 2022, and 3,575 options that vest and become exercisable on each of May 8, 2023, and May 8, 2024. Pursuant to the terms of the PSU award agreement, the vesting of 1,176 PSUs occurs on each of February 24, 2024 and February 24, 2025. Each PSU represents a contingent right to receive shares of Common Stock based upon the degree to which one or more of the performance metrics under the Company's 2023 Management Incentive Plan ("2023 MIP") are satisfied. The number of PSUs reported in columns 5, 7 and 9 of Table II reflects achievement at the target level of performance under the 2023 MIP. Based on actual results during the fiscal year ended December 31, 2023, the aggregate number of shares of Common Stock issued may range from zero shares to 167% of the target number of shares reported in columns 5, 7, and 9 of Table II. The PSUs will only vest upon the later of (i) the date the Compensation Committee or the Board of Directors of the Company certify that one or more of the performance metrics have been met under the 2023 MIP for the individual and (ii) the one-year anniversary of the date of grant. For Jeffrey Jacobs pursuant to the Power of Attorney previously filed. /s/ William E. McDonald 2023-03-10